Vitamin D Binding Protein Genotype and Osteoporosis

[1]  S. Ferrari,et al.  Pathophysiology of postmenopausal osteoporosis , 2010 .

[2]  A. Uitterlinden,et al.  Evidence for auto/paracrine actions of vitamin D in bone: 1a‐hydroxylase expression and activity in human bone cells , 2006 .

[3]  D. Baylink,et al.  Differential response in alveolar bone osteoclasts residing at two different bone sites , 1984, Calcified Tissue International.

[4]  M. Koršić.  [Pathophysiology of postmenopausal osteoporosis]. , 2006, Reumatizam.

[5]  S. Ralston,et al.  Polymorphisms of the interleukin-6 gene are associated with bone mineral density , 1997, Osteoporosis International.

[6]  A. Hofman,et al.  Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study. , 2005, American journal of human genetics.

[7]  R. Bouillon,et al.  Vitamin D metabolites in childhood nephrotic syndrome , 2005, Pediatric Nephrology.

[8]  T. Spector,et al.  The assessment of vertebral deformity: A method for use in population studies and clinical trials , 1993, Osteoporosis International.

[9]  P. Vestergaard,et al.  Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.

[10]  A. Uitterlinden,et al.  Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. , 2004, JAMA.

[11]  D. Bauer,et al.  Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  H. Møller,et al.  Female Premenopausal Fracture Risk Is Associated With Gc Phenotype , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  A. Braun,et al.  Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types , 1992, Human Genetics.

[14]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[15]  P. McMillan,et al.  Osteoclast recruitment and modulation by calcium deficiency, fasting, and calcium supplementation in the rat , 2004, Calcified Tissue International.

[16]  S. Inoue,et al.  Association of Molecular Variants, Haplotypes, and Linkage Disequilibrium Within the Human Vitamin D‐Binding Protein (DBP) Gene With Postmenopausal Bone Mineral Density , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  A. Hofman,et al.  Cdx‐2 Polymorphism in the Promoter Region of the Human Vitamin D Receptor Gene Determines Susceptibility to Fracture in the Elderly , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  A. Hofman,et al.  Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. , 2003, Human molecular genetics.

[19]  A. Hofman,et al.  The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  N. Swamy,et al.  Baculovirus‐expressed vitamin D‐binding protein‐macrophage activating factor (DBP‐maf) activates osteoclasts and binding of 25‐hydroxyvitamin D3 does not influence this activity , 2001, Journal of cellular biochemistry.

[21]  P. White,et al.  The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.

[22]  S. Liebhaber,et al.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. , 1999, The Journal of clinical investigation.

[23]  A. Hofman,et al.  RELATION OF ALLELES OF THE COLLAGEN TYPE I a 1 GENE TO BONE DENSITY AND THE RISK OF OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN , 2000 .

[24]  K. Soda,et al.  [Relationship between dietary calcium and bone mineral density before menopause]. , 1998, [Nihon koshu eisei zasshi] Japanese journal of public health.

[25]  R. Ray.  Molecular Recognition in Vitamin D-Binding Protein , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  A. Hofman,et al.  A large‐scale population‐based study of the association of vitamin D receptor gene polymorphisms with bone mineral density , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  P. Orchard,et al.  Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis. , 1996, Blood.

[28]  J. Haddad.  Plasma vitamin D-binding protein (Gc-globulin): Multiple tasks , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  S. Popoff,et al.  Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. , 1995, Bone.

[30]  A. Hofman,et al.  The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. , 1994, Bone and mineral.

[31]  C. Mendel.  The free hormone hypothesis: a physiologically based mathematical model. , 1989, Endocrine reviews.

[32]  G. D. Whedon,et al.  Vitamin D and bone health in the elderly. , 1982, The American journal of clinical nutrition.

[33]  P. D. de Moor,et al.  Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. , 1981, The Journal of clinical investigation.